UBS Downgrades Cree, Inc. (CREE) to Neutral; Near-term Concerns
- Stocks Tank as QE Nears End, Major Fund Winds Down, and Ebola Fears
- Bank of America (BAC) CEO Moynihan Elected as Chairman
- After-Hours Stock Movers 10/01: (RLD) (DRL) (DTV) Higher; (WILN) (NLNK) (PLTA) Lower (more...)
- Investors Yank $23.5 Billion From PIMCO in 3 Days Amid Gross Exit
UBS downgrades Cree, Inc. (Nasdaq: CREE) from Buy to Neutral. PT slashed from $83 to $64.
UBS analyst's highlighted points include: 1) Near term concern from demand air-pocket in consumer electronics LEDs; 2) But general lighting LED opportunity still showing signs of strong growth; and 3) Lowering estimates to account for less spot market sales of LED chips (FY11 and FY12 EPS estimates are $2.41 and $3.32 versus $2.50 and $3.49, previously)."
To see all the upgrades/downgrades on shares of CREE, visit our Analyst Ratings page.
Cree, Inc. develops and manufactures semiconductor materials and devices based on silicon carbide (SiC), gallium nitride (GaN) and related compounds.
You May Also Be Interested In
- UPDATE: Credit Suisse Downgrades Rush Enterprises Inc. (RUSHA) to Neutral
- Wedbush Downgrades eBay (EBAY) to Neutral
- Piper Jaffray Downgrades Vitamin Shoppe (VSI) to Neutral